SutroVax Announces $85M Series C Financing led by TPG Growth
Provides growth capital to advance pneumococcal vaccine to clinic and beyond
Preeminent executive vaccinologist, Moncef Slaoui, appointed Board Chairman
Strategic alignment established with Lonza Pharma & Biotech to create end-to-end supply chain
... Biopharmaceuticals, Venture Capital, Personnel SutroVax, pneumococcal vaccine, vaccine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Meningitis Vaccine | Pharmaceuticals | Pneomococcal Vaccine | Vaccines | Venture Capital